Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Enzo Biochem stock

ENZ
US2941001024
865607

Price

0.48
Today +/-
-0.01
Today %
-2.28 %

Enzo Biochem stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Enzo Biochem stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Enzo Biochem stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Enzo Biochem stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Enzo Biochem's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Enzo Biochem Stock Price History

DateEnzo Biochem Price
2/27/20250.48 undefined
2/26/20250.49 undefined
2/25/20250.49 undefined
2/24/20250.50 undefined
2/23/20250.50 undefined
2/20/20250.52 undefined
2/19/20250.53 undefined
2/18/20250.52 undefined
2/17/20250.50 undefined
2/13/20250.55 undefined
2/12/20250.51 undefined
2/11/20250.48 undefined
2/10/20250.52 undefined
2/9/20250.54 undefined
2/6/20250.56 undefined
2/5/20250.58 undefined
2/4/20250.59 undefined
2/3/20250.59 undefined
2/2/20250.58 undefined

Enzo Biochem Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Enzo Biochem, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Enzo Biochem from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Enzo Biochem’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Enzo Biochem. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Enzo Biochem’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Enzo Biochem’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Enzo Biochem’s growth potential.

Enzo Biochem Revenue, EBIT and net profit per share

DateEnzo Biochem RevenueEnzo Biochem EBITEnzo Biochem Net Income
202431.91 M undefined-9.73 M undefined-26.08 M undefined
202331.06 M undefined-19.54 M undefined20.29 M undefined
202232.64 M undefined-12.09 M undefined-18.26 M undefined
2021117.73 M undefined5.42 M undefined7.88 M undefined
202076 M undefined-23.7 M undefined-28.5 M undefined
201981.2 M undefined-24.2 M undefined2.5 M undefined
2018101 M undefined-7.1 M undefined-10.3 M undefined
2017105.1 M undefined-1.4 M undefined-2.5 M undefined
2016102.8 M undefined-3.9 M undefined45.3 M undefined
201597.6 M undefined-3.9 M undefined-2.3 M undefined
201495.9 M undefined-6.3 M undefined-10 M undefined
201393.7 M undefined-13.2 M undefined-18.2 M undefined
2012103.1 M undefined-12.2 M undefined-39.3 M undefined
2011102 M undefined-9.2 M undefined-13 M undefined
201097.1 M undefined-16.7 M undefined-22.2 M undefined
200989.6 M undefined-19.2 M undefined-23.6 M undefined
200877.8 M undefined-9.2 M undefined-10.7 M undefined
200752.9 M undefined-8 M undefined-13.3 M undefined
200639.8 M undefined-12.8 M undefined-15.7 M undefined
200543.4 M undefined-4.8 M undefined3 M undefined

Enzo Biochem Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
45691212151919202022313434404442525452414339527789971021039395971021051018176117323131
-25.0020.0050.0033.33-25.0026.67-5.26-10.0040.919.68-17.6510.00-4.5523.813.85-3.70-21.154.88-9.3033.3348.0815.588.995.150.98-9.712.152.115.152.94-3.81-19.80-6.1753.95-72.65-3.13-
100.00100.0083.3377.7875.0075.0073.3368.4268.4265.0055.0054.5554.8455.8855.8860.0063.6480.9578.8577.7875.0068.2965.1258.9753.8546.7540.4546.3947.0645.6340.8643.1643.3044.1242.8639.6028.4030.2645.3040.6335.4845.16
455799111313131112171919242834414239282823283636454847384142454540232353131114
1111-1-3-4-2-110-655-71366663-63-15-13-10-23-22-13-39-18-10-245-2-102-287-1820-26
-----200.00200.0033.33-50.00450.00---183.33--240.00-114.29200.00100.00----50.00-300.00-150.00-600.00-13.33-23.08130.00-4.35-40.91200.00-53.85-44.44-80.00-2,350.00-104.44400.00-120.00-1,500.00-125.00-357.14-211.11-230.00
14.714.714.814.91414.514.514.514.518.322.526.226.726.328.128.429.532.832.632.332.231.732.832.23536.937.53838.438.839.642.645.446.646.44747.547.748.3348.5949.1650.9
------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Enzo Biochem Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Enzo Biochem is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                                   
21.420.719.55350.343.830.418.40.60.80.74.211.117.825.333.543.25158.767.178.471.783.769.9105.178.350.233.624.215.1917.518.167.864.26060.147.943.521.682.3752.37
0.10.10.40.60.70.945.86.76.459.310.910.51214.21520.224.620.317.314.813.410.414.415.312.51315.214.112.312.512.114.615.213.110.79.110.24.764.813.99
0.40.20.10.20.30.30.20.20.1006.50004.9000003.900000000006.7000000000
0.20.30.50.70.70.91.11.41.51.61.72.12.21.81.61.41.41.824.23.43.42.92.479.59.38.99.38.88.88.77.4777.37.87.812.659.527.946.83
000.91.92.8110.90.80.70.63.76.15.86.81.324.13.24.33.83.84.13.41.82.52.52.32.72.42.52.12.22.12.72.72.744.236.943.346.84
22.121.321.456.454.846.936.726.79.79.5825.830.335.945.755.361.677.188.595.9102.997.6104.186.1128.3105.674.557.851.440.432.640.846.591.589.183.181.368.870.5842.8298.4670.03
0.40.40.74.66.17.311.519.223.223.723.223.613.93.12.92.62.82.82.72.32.22.42.75.86.69.111.311.910.39.18.67.77.98.27.97.614.334.433.6116.0216.7115.2
000000000000000000000000000000000000000000
00000000000009.14.7000000000000000000000000000
00000000000054.94.84.64.343.93.63.22.61.31.39.317.72220.42011.89.98.16.24.42.91.910.50.24000
000000000000109.79.38.98.68.27.87.57.57.57.57.513.721.324.924.927.47.57.57.57.57.57.57.57.57.57.45000
001.714.314.815.726.420.616.516.716.515.713.30.20.20.71.50.10.10.10.20.20.90.91.10.80.40.30.40.40.40.40.40.30.31.52.41.41.8116.776.710.53
0.40.42.418.920.92337.939.839.740.439.739.342.22721.916.817.215.114.513.513.112.712.415.530.748.958.657.558.128.826.423.72220.418.618.525.243.843.1132.7923.4215.73
22.521.723.875.375.769.974.666.549.449.947.765.172.562.967.672.178.892.2103109.4116110.3116.5101.6159154.5133.1115.3109.569.25964.568.5111.9107.7101.6106.5112.6113.6975.61121.8885.76
                                                                                   
100100100100100100100100100200200200200200200200200300300300300300300300400400400400400400400400500500500500500500485487499521
17.517.62020.120.719.419.419.519.551.958.271.881.683.590.792.192.597.4133.1160.5199.1205.9230.6236295.9303.8306.3306.6305.8304.4304.3317.2325326.3328.3330.8332.7334.5337.13339.46344.44348.13
0.31.62.94.42.8-0.3-4.4-6.9-18.5-19.1-26-20.7-20.7-28.4-27-23.6-17.1-10.4-35.9-56.1-89.9-96.1-116.6-132.2-145.5-156.2-179.7-202-214.9-254.2-272.4-282.4-284.7-239.4-241.9-252.2-249.7-278.3-270.38-288.64-268.35-294.43
00000000000000000000-0.1-0.2-0.1001.60.30.93.81.61.91.71.92.222.12.61.71.353.151.881.89
000000000000000000000000000000000000000000
17.919.32324.623.619.215.112.71.13332.451.361.155.363.968.775.687.397.5104.7109.4109.9114.2104.1150.8149.6127.3105.995.152.234.236.942.789.688.981.286.158.468.5954.4678.4656.11
0.10.10.10.30.20.30.60.82.52.51.14.41.61.31.11.41.21.521.51.32.12.41.34.14.34.26.57.998.58.28.89.910.49.57.38.58.123.723.581.38
0.310.61.72.41.92.12.44.93.93.723.15.11.10.80.91.81.31.43.63.24.94.48.47.48.48.58.29.811.812.911.38.26.710.18.414.415.059.0812.726.56
0000002.62.33.83.83.701.100.10.20.30.400.20.20.10.50.21.91.61.30.61.70.10.20.60.90.90.70.402.52.68021.116.79
0000000000000000000000000000003.3331.60007002.510
0000000.20.232.21.91.92.20.10.10.10000000000000000.10.10000.20.40.30.230.230.080.08
0.41.10.722.62.25.55.743.412.110.48.65.96.52.42.42.43.73.33.15.15.47.85.914.413.313.915.617.818.923.924.82420.617.820.216.132.726.0813.0239.9924.79
00048.349.248.349.245.84.54.24.24.44.70.100000000.30.200000000.80.70.60.90.60.44.64.64.474.080.270.19
0000.40.10.10.10.10.10.20.20.2000000.71.41.21.20.40.301.72.42.42.62.90.90.20.20000000000
4.31.200004.72.30.20.30.50.70.81110.90.80.70.30.10000.90.500.10.10.101.61.20.80.40016.714.564.053.164.67
4.31.2048.749.348.45448.24.84.74.95.35.51.1110.91.52.11.51.30.70.502.62.92.42.73112.51.81.710.44.621.319.038.133.434.86
4.72.30.750.751.950.659.553.948.216.815.313.911.47.63.43.43.35.25.44.66.46.18.35.91716.216.318.320.819.924.927.325.822.318.820.620.75445.1121.1543.4229.65
22.621.623.775.375.569.874.666.649.349.847.765.272.562.967.372.178.992.5102.9109.3115.8116122.5110167.8165.8143.6124.2115.972.159.164.268.5111.9107.7101.8106.8112.4113.6975.61121.8885.76
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Enzo Biochem provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Enzo Biochem's financial health and stability.

Assets

Enzo Biochem's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Enzo Biochem must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Enzo Biochem after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Enzo Biochem's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
1-1-3-4-2-110-655-71366663-63-15-13-10-23-22-12-39-18-9-245-2-102-287-1820
00000111111111111122112344443333332222
00000000-3200-1-10200-10000000-100000000000
0-3-1-2-300-1-4-17-10-5-5-15-17-14-3-121-20-40-2-50-10-90-5-1-37-4-618
03210727-216135101012141491256859773265555742-38-78
03344300000000000000000000000000000001
01000000001000024003-1-10000000001000000
1-1-1-4-5-220-396781148912-513-10-3-8-11-13-8-5-10-1-3530-24-170-16-36
-1-1-1-4-8-7-2-1-1-1-1-1-1-1-1-1-1-1-1-1-4-1-3-2-3-1-100-1-1-1-1-8-2-4-3-2
-12-616-10-10-3-1-1-1-1-1-1-1-1-1-1-1-16-492-18-18-601513700-1-1-1-1-8-2-342598
-10-418-6-2300000000000-15-2106-16-15-571814800000000-3028101
00000000000000000000000000000000000000
450-10-20000-200000000000000000200-2-204700-1
0000000071111041000005700000111600000000
41000-4-100801010410000057000004106-1-104700-1
-3.00----2.00-1.00--------------------------------
00000000000000000000000000000000000000
31-714-15-19-600366789778-3-822-735-26-71150-68049-3-40-12-34860
0.62-3.63-3.15-8.78-13.59-9.410-0.3-4.717.665.146.527.249.53.686.428.4510.79-7.3311.84-14.41-5.22-11.79-14.19-16.71-9.55-7.33-11.01-2.54-5.4851.6-1.96-4.63-3.32-19.35-4.05-20.06-39.74
00000000000000000000000000000000000000

Enzo Biochem stock margins

The Enzo Biochem margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Enzo Biochem. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Enzo Biochem.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Enzo Biochem's sales revenue. A higher gross margin percentage indicates that the Enzo Biochem retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Enzo Biochem's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Enzo Biochem's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Enzo Biochem's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Enzo Biochem. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Enzo Biochem's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Enzo Biochem Margin History

Enzo Biochem Gross marginEnzo Biochem Profit marginEnzo Biochem EBIT marginEnzo Biochem Profit margin
202445.86 %-30.5 %-81.73 %
202337.24 %-62.91 %65.32 %
202241.14 %-37.04 %-55.94 %
202145.51 %4.6 %6.69 %
202031.32 %-31.18 %-37.5 %
201928.57 %-29.8 %3.08 %
201840.2 %-7.03 %-10.2 %
201743.39 %-1.33 %-2.38 %
201644.36 %-3.79 %44.07 %
201543.85 %-4 %-2.36 %
201443.48 %-6.57 %-10.43 %
201341.52 %-14.09 %-19.42 %
201245.68 %-11.83 %-38.12 %
201147.25 %-9.02 %-12.75 %
201046.34 %-17.2 %-22.86 %
200940.74 %-21.43 %-26.34 %
200846.79 %-11.83 %-13.75 %
200754.25 %-15.12 %-25.14 %
200659.05 %-32.16 %-39.45 %
200565.44 %-11.06 %6.91 %

Enzo Biochem Stock Sales Revenue, EBIT, Earnings per Share

The Enzo Biochem earnings per share therefore indicates how much revenue Enzo Biochem has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Enzo Biochem earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Enzo Biochem's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Enzo Biochem’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Enzo Biochem's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Enzo Biochem Revenue, EBIT and net profit per share

DateEnzo Biochem Sales per ShareEnzo Biochem EBIT per shareEnzo Biochem Earnings per Share
20240.63 undefined-0.19 undefined-0.51 undefined
20230.63 undefined-0.4 undefined0.41 undefined
20220.67 undefined-0.25 undefined-0.38 undefined
20212.44 undefined0.11 undefined0.16 undefined
20201.59 undefined-0.5 undefined-0.6 undefined
20191.71 undefined-0.51 undefined0.05 undefined
20182.15 undefined-0.15 undefined-0.22 undefined
20172.27 undefined-0.03 undefined-0.05 undefined
20162.21 undefined-0.08 undefined0.97 undefined
20152.15 undefined-0.09 undefined-0.05 undefined
20142.25 undefined-0.15 undefined-0.23 undefined
20132.37 undefined-0.33 undefined-0.46 undefined
20122.66 undefined-0.31 undefined-1.01 undefined
20112.66 undefined-0.24 undefined-0.34 undefined
20102.56 undefined-0.44 undefined-0.58 undefined
20092.39 undefined-0.51 undefined-0.63 undefined
20082.11 undefined-0.25 undefined-0.29 undefined
20071.51 undefined-0.23 undefined-0.38 undefined
20061.24 undefined-0.4 undefined-0.49 undefined
20051.32 undefined-0.15 undefined0.09 undefined

Enzo Biochem business model

Enzo Biochem Inc is a US-based company operating in the biotechnology sector. It was founded in 1976 by Elazar Rabbani and is headquartered in New York. The company focuses on developing, producing, and marketing innovative diagnostic and therapeutic products for the medical industry. Enzo Biochem Inc's business model is based on the application of modern technologies for the development and synthesis of molecules for medical technology and life sciences. At the same time, the company also offers diagnostic testing systems and clinical laboratory services to its customers. Enzo Biochem's business model is therefore diverse and covers various areas. Enzo Biochem divides its business into three main segments: life sciences, clinical labs, and therapeutics. In the life sciences segment, the company engages in research and development of technologies for synthesizing molecules for medical technology. In the clinical labs segment, Enzo Biochem offers diagnostic testing systems and clinical laboratory services for use in medical diagnostics. The therapeutics segment manufactures therapeutic products for the treatment of viral infections. Enzo Biochem's product offering includes a wide range of products and services. This includes molecules for medical technology, diagnostic testing systems, and therapy products for viral infections. The product lines of Enzo Biochem include: - Molecules for medical technology: Enzo Biochem has developed a wide range of molecules for medical technology and is a leader in this field. These molecules include proteins, antibodies, and other biomolecules. The company also offers custom molecules for specific applications. - Diagnostic testing systems: The company offers a wide range of diagnostic testing systems tailored to the needs of laboratories and clinics. The tests include tests for infectious diseases, cancer, metabolic disorders, and other diseases. - Clinical laboratory services: Enzo Biochem provides a wide range of clinical laboratory services, including blood tests, microbiological tests, urine, stool, and body fluid tests, as well as histological analysis of tissue samples. - Therapy products: Enzo Biochem has developed a broad portfolio of therapy products for the treatment of viral infections. These products include immunomodulators, antivirals, and other therapeutics aimed at combating various pathogens. Enzo Biochem has made a name for itself in the biotechnology industry through continuous innovation and high-quality products. The company has also engaged in partnerships, acquisitions, and joint ventures to expand its global footprint. It has a global presence and works with leading pharmaceutical and biotech companies from around the world. Overall, Enzo Biochem has established itself as a leading biotechnology company operating in the fields of life sciences, clinical labs, and therapeutics. The company offers a wide range of products and services tailored to the needs of laboratories and clinics. Enzo Biochem has established itself as an innovation leader in the biotechnology industry and is committed to further expanding its business through the development of new products and technologies. Enzo Biochem is one of the most popular companies on Eulerpool.com.

Enzo Biochem SWOT Analysis

Strengths

Enzo Biochem Inc. possesses several strengths that contribute to its competitive advantage:

  • Strong patent portfolio: Enzo Biochem holds a significant number of patents for its innovative technologies and products, providing a solid foundation for future growth.
  • Diverse product portfolio: The company offers a wide range of products and services, including molecular biology reagents, diagnostic kits, and clinical laboratory services, which helps to diversify its revenue streams and mitigate risk.
  • Strategic partnerships: Enzo Biochem has established strategic collaborations with leading research institutions and healthcare organizations, facilitating access to new markets, expertise, and resources.
  • Experienced management team: The company is led by a highly skilled and knowledgeable management team with extensive industry experience, ensuring effective decision-making and execution of growth strategies.

Weaknesses

Despite its strengths, Enzo Biochem Inc. faces certain weaknesses that could hinder its performance:

  • High research and development costs: Developing cutting-edge products and technologies requires substantial investment in research and development, potentially straining the company's financial resources.
  • Reliance on key customers: Enzo Biochem heavily depends on a few key customers for a significant portion of its revenue, making it vulnerable to potential changes in demand or loss of business from these customers.
  • Limited global presence: The company's operations are primarily concentrated in certain regions, limiting its exposure to international markets and potential growth opportunities.

Opportunities

Enzo Biochem Inc. can capitalize on various opportunities to enhance its market position and profitability:

  • Expanding product offerings: The company can further diversify its product portfolio by investing in new research and development initiatives, potentially addressing unmet needs in the healthcare and life sciences sectors.
  • Growing demand for personalized medicine: The increasing focus on personalized medicine presents an opportunity for Enzo Biochem to develop and commercialize advanced diagnostic tools and therapies tailored to individual patients.
  • Emerging markets: Penetrating emerging markets, such as Asia and Latin America, can provide Enzo Biochem with new avenues for revenue growth, given the rising healthcare expenditure and increasing awareness about advanced healthcare technologies.

Threats

Enzo Biochem Inc. faces several threats that could impact its business and market position:

  • Intense competition: The life sciences and molecular diagnostics industry is highly competitive, with numerous established players and new entrants constantly vying for market share. This could put pressure on Enzo Biochem's pricing and profitability.
  • Regulatory challenges: Compliance with evolving regulations, such as those related to clinical laboratory operations and the approval process for new products, can pose challenges and lead to delays in commercialization.
  • Economic uncertainties: Fluctuations in the global economy, such as recessions or economic downturns, can impact healthcare spending and investment in research and development, influencing Enzo Biochem's revenue growth and profitability.

Enzo Biochem Revenue by Segment

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Enzo Biochem Revenue by Segment

Segmente20222021202020192018
Product Revenue-----

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Enzo Biochem Revenue by Segment

Segmente20222021202020192018
Product Revenue32.64 M USD30.75 M USD11.98 M USD--
Service----74.78 M USD

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Enzo Biochem Revenue by Segment

Segmente20222021202020192018
Royalty and License Fees-----

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Enzo Biochem Revenue by Segment

Segmente20222021202020192018
Clinical Laboratory Services----74.78 M USD
Product----29.22 M USD
Royalty and License Fees----712,000 USD

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Enzo Biochem Revenue by Segment

Segmente20222021202020192018
Clinical services74.43 M USD86.98 M USD---
Clinical Services--47.96 M USD--
Life Sciences----29.94 M USD

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Enzo Biochem Revenue by Segment

Segmente20222021202020192018
Consolidated107.07 M USD117.73 M USD74.53 M USD--
Clinical Laboratory Services74.43 M USD86.98 M USD---
Life Sciences Products32.64 M USD30.75 M USD---
Clinical Services---51.12 M USD-

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Enzo Biochem Revenue by Segment

Segmente20222021202020192018
Clinical Labs--47.96 M USD51.12 M USD74.78 M USD
Life Sciences--26.56 M USD30.06 M USD-

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Enzo Biochem Revenue by Segment

Segmente20222021202020192018
Consolidated----104.71 M USD
Products---30.06 M USD-

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Enzo Biochem Revenue by Segment

Segmente20222021202020192018
Consolidated---81.17 M USD-

Enzo Biochem Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Enzo Biochem Revenue by Segment

DateEuropeForeign CountriesOther International CountriesRest of worldSWITZERLANDUNITED KINGDOMUnited States
20228.57 M USD------94.21 M USD
20214.74 M USD------102.6 M USD
2020---10.18 M USD-608,000 USD1.19 M USD64.04 M USD
2019-5.92 M USD8.78 M USD4.56 M USD7.17 M USD2.61 M USD1.61 M USD21.27 M USD
2018--9.33 M USD4.89 M USD-2.58 M USD1.85 M USD19.9 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Enzo Biochem Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Enzo Biochem historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Enzo Biochem shares outstanding

The number of shares was Enzo Biochem in 2024 — This indicates how many shares 50.902 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Enzo Biochem earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Enzo Biochem's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Enzo Biochem’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Enzo Biochem's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Enzo Biochem stock splits

In Enzo Biochem's history, there have been no stock splits.

Enzo Biochem dividend history and estimates

In 2024, Enzo Biochem paid a dividend amounting to 0.1 USD. Dividend means that Enzo Biochem distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Enzo Biochem provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Enzo Biochem’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Enzo Biochem's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Enzo Biochem Dividend History

DateEnzo Biochem Dividend
20240.1 undefined
Enzo Biochem does not pay out any dividends.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Enzo Biochem.

Enzo Biochem latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2019-0.15 -0.14  (7.59 %)2019 Q3
3/31/2019-0.13 -0.18  (-37.09 %)2019 Q2
12/31/2018-0.11 -0.13  (-17.01 %)2019 Q1
9/30/2018-0.06 -0.12  (-98.02 %)2018 Q4
6/30/2018-0.02 -0.06  (-197.03 %)2018 Q3
3/31/2018-0.01 -0.04  (-296.04 %)2018 Q2
12/31/2017-0.01 -0.01  (0.99 %)2018 Q1
9/30/2017-0.02 0  (100 %)2017 Q4
6/30/2017-0.03 0  (100 %)2017 Q3
3/31/2017-0.04 -0.02  (50.5 %)2017 Q2
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the Enzo Biochem stock

Eulerpool World ESG Rating (EESG©)

50/ 100

🌱 Environment

49

👫 Social

65

🏛️ Governance

34

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Enzo Biochem shareholders

%
Name
Stocks
Change
Date
9.90795 % Harbert Fund Advisors, Inc5,175,913012/31/2024
9.46095 % Wolf (James G)4,942,400233,90011/27/2024
8.52683 % Radoff (Bradley Louis)4,454,414142,8971/16/2025
4.78560 % 1 Main Capital Partners, LP2,500,000-374,12512/31/2023
4.53205 % Renaissance Technologies LLC2,367,543-159,98612/31/2024
3.55858 % The Vanguard Group, Inc.1,859,002-17,62012/31/2024
2.83641 % Potomac Capital Management Inc.1,481,74226,74212/31/2023
1.70905 % BlackRock Institutional Trust Company, N.A.892,80668812/31/2024
1.54651 % Mink Brook Asset Management LLC807,899807,89912/31/2024
1.44230 % Erfanian (Hamid)753,460360,29611/27/2024
1
2
3
4
5
...
10

Enzo Biochem Executives and Management Board

Ms. Kara Cannon

(55)
Enzo Biochem Chief Executive Officer, Chief Operating Officer
Compensation 1.22 M

Ms. Patricia Eckert

(46)
Enzo Biochem Chief Financial Officer
Compensation 453,559

Dr. Mary Tagliaferri

(57)
Enzo Biochem Independent Director
Compensation 210,000

Mr. Bradley Radoff

(50)
Enzo Biochem Independent Director
Compensation 195,000

Mr. Ian Walters

(55)
Enzo Biochem Independent Director
Compensation 190,000
1
2

Enzo Biochem Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Progyny Stock
Progyny
SupplierCustomer0,690,810,790,400,510,76
Immutep Stock
Immutep
SupplierCustomer-0,14-0,340,270,480,520,71
UnitedHealth Group Stock
UnitedHealth Group
SupplierCustomer-0,230,570,22-0,43-0,510,47
1

Most common questions regarding Enzo Biochem

What values and corporate philosophy does Enzo Biochem represent?

Enzo Biochem Inc represents the values of innovation, excellence, and integrity. The company is committed to advancing scientific research and delivering cutting-edge diagnostic and therapeutic solutions. Enzo Biochem Inc embraces a corporate philosophy centered around quality, accuracy, and collaboration. They strive to provide accurate and reliable products and services to enable healthcare professionals to improve patient outcomes. With a strong focus on research and development, Enzo Biochem Inc aims to address significant unmet medical needs and drive advancements in the field of life sciences.

In which countries and regions is Enzo Biochem primarily present?

Enzo Biochem Inc is primarily present in the United States.

What significant milestones has the company Enzo Biochem achieved?

Enzo Biochem Inc has achieved several significant milestones throughout its history. In 1976, the company was founded by Dr. Elazar Rabbani and developed innovative technologies for the life sciences and biotechnology sectors. In 1985, Enzo introduced the first commercial oligo synthesizer, revolutionizing DNA research. The company continued to expand its portfolio and in the late 1990s, launched diagnostic products for molecular oncology and genetics. Enzo has also successfully obtained numerous patents for its inventions. Over the years, Enzo Biochem Inc has established itself as a leading player in the life sciences industry with its strong commitment to innovation, research, and development.

What is the history and background of the company Enzo Biochem?

Enzo Biochem Inc, founded in 1976, is a leading life sciences and biotechnology company based in New York. It specializes in the development, production, and commercialization of innovative diagnostic and research products worldwide. Enzo Biochem is known for its cutting-edge technology platforms, including gene regulation, therapeutics, and molecular diagnostic systems. The company's focus extends to areas such as biomarkers, infectious diseases, and cancer diagnostics. With a strong history of innovation and a commitment to delivering high-quality products and services, Enzo Biochem continues to play a significant role in advancing the field of life sciences and improving patient care.

Who are the main competitors of Enzo Biochem in the market?

The main competitors of Enzo Biochem Inc in the market include companies such as Thermo Fisher Scientific, Quidel Corporation, and Bio-Rad Laboratories.

In which industries is Enzo Biochem primarily active?

Enzo Biochem Inc is primarily active in the life sciences and biotechnology industry.

What is the business model of Enzo Biochem?

Enzo Biochem Inc is a life sciences and biotechnology company. Its business model encompasses the development, manufacturing, and commercialization of innovative diagnostic and research products. The company offers a diverse range of products and services catering to the life sciences industry. These include molecular diagnostics, immunohistochemistry, flow cytometry, and drug discovery research tools. Enzo Biochem Inc also operates clinical reference laboratories that provide a wide array of testing services. By leveraging its proprietary technology platforms, the company aims to facilitate advancements in personalized medicine and scientific research. Through collaborations and strategic partnerships, Enzo Biochem Inc strives to contribute to advancements in healthcare and improve patient outcomes.

What is the P/E ratio of Enzo Biochem 2025?

The P/E ratio cannot be calculated for Enzo Biochem at the moment.

What is the P/S ratio of Enzo Biochem 2025?

The P/S cannot be calculated for Enzo Biochem currently.

What is the Quality Investing of Enzo Biochem?

The Quality Investing for Enzo Biochem is 1/10.

What is the revenue of Enzo Biochem 2025?

The revenue cannot currently be calculated for Enzo Biochem.

How high is the profit of Enzo Biochem 2025?

The profit cannot currently be calculated for Enzo Biochem.

What is the business model of Enzo Biochem

Enzo Biochem Inc is a leading company in the field of life science research, offering a wide range of products and services. The company operates in three main business areas: life sciences, clinical labs, and therapeutics. In the life sciences field, the company provides researchers with a comprehensive range of products and services to better understand the fundamentals of life, including enzymes and proteins, genetic engineering, and immunology. In the clinical lab services area, Enzo Biochem Inc offers specialized testing procedures and preparation technologies to its customers, operating multiple clinical labs in New York and New Jersey. The company also develops a wide range of therapeutics for the treatment of diseases and disorders, based on genetic and biochemical technologies to understand disease mechanisms and develop more effective treatment methods. Enzo Biochem Inc places a strong emphasis on innovation, continuously investing in research and development to provide customers with value-added technologies and methods. Additionally, the company is committed to sustainability and environmental friendliness, developing technologies and products that meet customer requirements while minimizing environmental impact. Overall, Enzo Biochem Inc provides customers with a comprehensive range of products and services to address the challenges of life science research and development, with a focus on innovation and customer satisfaction.

What is the Enzo Biochem dividend?

Enzo Biochem pays a dividend of 0 USD distributed over payouts per year.

How often does Enzo Biochem pay dividends?

The dividend cannot currently be calculated for Enzo Biochem or the company does not pay out a dividend.

What is the Enzo Biochem ISIN?

The ISIN of Enzo Biochem is US2941001024.

What is the Enzo Biochem WKN?

The WKN of Enzo Biochem is 865607.

What is the Enzo Biochem ticker?

The ticker of Enzo Biochem is ENZ.

How much dividend does Enzo Biochem pay?

Over the past 12 months, Enzo Biochem paid a dividend of 0.1 USD . This corresponds to a dividend yield of about 20.79 %. For the coming 12 months, Enzo Biochem is expected to pay a dividend of 0.1 USD.

What is the dividend yield of Enzo Biochem?

The current dividend yield of Enzo Biochem is 20.79 %.

When does Enzo Biochem pay dividends?

Enzo Biochem pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzo Biochem?

Enzo Biochem paid dividends every year for the past 1 years.

What is the dividend of Enzo Biochem?

For the upcoming 12 months, dividends amounting to 0.1 USD are expected. This corresponds to a dividend yield of 20.79 %.

In which sector is Enzo Biochem located?

Enzo Biochem is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzo Biochem kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzo Biochem from 12/2/2024 amounting to 0.1 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Enzo Biochem pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of Enzo Biochem in the year 2024?

In the year 2024, Enzo Biochem distributed 0 USD as dividends.

In which currency does Enzo Biochem pay out the dividend?

The dividends of Enzo Biochem are distributed in USD.

All fundamentals about Enzo Biochem

Our stock analysis for Enzo Biochem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzo Biochem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.